What top creators are saying about Curis, Inc.(CRIS)

A biotechnology company focused on developing cancer therapeutics.

2 AI-extracted insights from 1 source โ€” podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment โ€” last 30 days

Not enough scored insights about Curis, Inc. in the last 30 days yet.

Top creators covering Curis, Inc. (CRIS)

The 1 sources with the most insights about Curis, Inc. on Kazuha.

Latest insights about Curis, Inc. (CRIS)

AI-generated insights from podcasts, YouTube videos, and X posts โ€” ordered by most recent.

Thursday, September 11, 2025

Very Bullish

The CEO made his first-ever stock purchases, totaling around $700,000, just before a major FDA ruling, which is considered a very bullish and compelling signal of confidence.

Saturday, August 16, 2025

Very Bullish

The CEO made his first-ever purchase of the stock ahead of expected clinical trial results or product launches, a highly bullish signal suggesting confidence in a positive outcome.

Discussed alongside Curis, Inc. (CRIS)

Other assets that creators frequently mention in the same content as Curis, Inc..

Frequently asked

Which podcasters and creators cover Curis, Inc. (CRIS) the most?

The most active sources covering Curis, Inc. (CRIS) on Kazuha are @ceowatcher. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Curis, Inc. (CRIS) are on Kazuha?

Kazuha has indexed 2 AI-extracted insights about Curis, Inc. (CRIS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Curis, Inc. (CRIS)?

Creators covering Curis, Inc. (CRIS) most frequently also discuss ANET, DLTR, CNC, REZI, HIMS. See the "Discussed alongside" section above for full asset pages.